Search
for
Sort by
Research 181–210 of 1000+
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Integration Analysis of Transcriptome and Proteome Reveal the Mechanisms of Goat Wool Bending
- Integration Analysis of Hair Follicle Transcriptome and Proteome Reveals the Mechanisms Regulating Wool Fiber Diameter in Angora Rabbits
- Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity
- A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
- Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- PKC downregulation upon rapamycin treatment attenuates mitochondrial disease
- VDAC2 Mediates the Apoptosis of Cashmere Goat Hair Follicle Stem Cells Through the P53 Signaling Pathway
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- PCSK9: From Nature’s Loss to Patient’s Gain
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Dermatologic Adverse Events from Cancer Treatments
- The JAK/STAT signaling pathway: from bench to clinic
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Mycophenolate Antagonizes IFN-γ-Induced Catagen-Like Changes via β-Catenin Activation in Human Dermal Papilla Cells and Hair Follicles
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions